Regeneron Pharmaceuticals Inc and Decibel Therapeutics have announced a collaboration to discover and develop new potential therapeutics to protect, repair, and restore hearing. Regeneron will provide Decibel with broad access to its proprietary suite of technologies to support Decibel’s goal of discovering important new medicines for hearing. Financial terms were not disclosed.